nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—osteoarthritis—Prednisone—systemic scleroderma	0.473	1	CpDpCtD
Ketoprofen—CYP2C8—Mometasone—systemic scleroderma	0.0436	0.126	CbGbCtD
Ketoprofen—SLCO1A2—Prednisone—systemic scleroderma	0.0348	0.101	CbGbCtD
Ketoprofen—SLC22A6—Captopril—systemic scleroderma	0.0335	0.097	CbGbCtD
Ketoprofen—ALB—Captopril—systemic scleroderma	0.0286	0.0826	CbGbCtD
Ketoprofen—SLC22A11—Methotrexate—systemic scleroderma	0.0261	0.0756	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—systemic scleroderma	0.0249	0.072	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—systemic scleroderma	0.0243	0.0704	CbGbCtD
Ketoprofen—ALB—Mycophenolate mofetil—systemic scleroderma	0.0225	0.0651	CbGbCtD
Ketoprofen—CYP2C9—Leflunomide—systemic scleroderma	0.0196	0.0568	CbGbCtD
Ketoprofen—ALB—Prednisone—systemic scleroderma	0.018	0.052	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—systemic scleroderma	0.0175	0.0505	CbGbCtD
Ketoprofen—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0174	0.0503	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—systemic scleroderma	0.0152	0.044	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—systemic scleroderma	0.0106	0.0306	CbGbCtD
Ketoprofen—ALB—Methotrexate—systemic scleroderma	0.00902	0.0261	CbGbCtD
Ketoprofen—CYP2C9—cardial valve—systemic scleroderma	0.00635	0.266	CbGeAlD
Ketoprofen—CXCR1—lung—systemic scleroderma	0.00213	0.0892	CbGeAlD
Ketoprofen—PTGS2—skeletal joint—systemic scleroderma	0.00199	0.0832	CbGeAlD
Ketoprofen—CXCL8—TSLP Signaling Pathway—TNFSF4—systemic scleroderma	0.00142	0.0573	CbGpPWpGaD
Ketoprofen—CXCR1—Differentiation Pathway—CSF1—systemic scleroderma	0.0013	0.0524	CbGpPWpGaD
Ketoprofen—CXCL8—smooth muscle tissue—systemic scleroderma	0.00115	0.048	CbGeAlD
Ketoprofen—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00103	0.624	CbGdCrCtD
Ketoprofen—PTGS1—artery—systemic scleroderma	0.000869	0.0364	CbGeAlD
Ketoprofen—PTGS2—artery—systemic scleroderma	0.000831	0.0348	CbGeAlD
Ketoprofen—CXCL8—lung—systemic scleroderma	0.000755	0.0317	CbGeAlD
Ketoprofen—SLC22A11—digestive system—systemic scleroderma	0.000749	0.0314	CbGeAlD
Ketoprofen—PTGS1—endothelium—systemic scleroderma	0.000734	0.0308	CbGeAlD
Ketoprofen—SLC22A7—digestive system—systemic scleroderma	0.000731	0.0307	CbGeAlD
Ketoprofen—PTGS2—endothelium—systemic scleroderma	0.000702	0.0294	CbGeAlD
Ketoprofen—CXCL8—Spinal Cord Injury—AIF1—systemic scleroderma	0.000679	0.0274	CbGpPWpGaD
Ketoprofen—PTGS1—blood vessel—systemic scleroderma	0.000677	0.0284	CbGeAlD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.000658	0.0266	CbGpPWpGaD
Ketoprofen—PTGS2—blood vessel—systemic scleroderma	0.000647	0.0271	CbGeAlD
Ketoprofen—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000621	0.376	CbGdCrCtD
Ketoprofen—SLCO1A2—digestive system—systemic scleroderma	0.000443	0.0186	CbGeAlD
Ketoprofen—CXCL8—TSLP Signaling Pathway—STAT4—systemic scleroderma	0.000435	0.0176	CbGpPWpGaD
Ketoprofen—ABCC4—digestive system—systemic scleroderma	0.000426	0.0179	CbGeAlD
Ketoprofen—ABCC4—tendon—systemic scleroderma	0.000405	0.017	CbGeAlD
Ketoprofen—CXCL8—AP-1 transcription factor network—COL1A2—systemic scleroderma	0.000395	0.016	CbGpPWpGaD
Ketoprofen—CXCR1—Chemokine receptors bind chemokines—CCL2—systemic scleroderma	0.000388	0.0157	CbGpPWpGaD
Ketoprofen—SLCO1A2—lung—systemic scleroderma	0.00037	0.0155	CbGeAlD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.000356	0.0144	CbGpPWpGaD
Ketoprofen—ABCC4—lung—systemic scleroderma	0.000356	0.0149	CbGeAlD
Ketoprofen—PTGS1—connective tissue—systemic scleroderma	0.000347	0.0146	CbGeAlD
Ketoprofen—CXCL8—Bladder Cancer—MMP1—systemic scleroderma	0.000345	0.0139	CbGpPWpGaD
Ketoprofen—CXCL8—ATF4 activates genes—CCL2—systemic scleroderma	0.000333	0.0135	CbGpPWpGaD
Ketoprofen—PTGS2—connective tissue—systemic scleroderma	0.000332	0.0139	CbGeAlD
Ketoprofen—CXCL8—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000332	0.0134	CbGpPWpGaD
Ketoprofen—PTGS1—smooth muscle tissue—systemic scleroderma	0.000318	0.0133	CbGeAlD
Ketoprofen—ABCC4—Platelet degranulation—SELP—systemic scleroderma	0.000316	0.0128	CbGpPWpGaD
Ketoprofen—PTGS1—skin of body—systemic scleroderma	0.000314	0.0131	CbGeAlD
Ketoprofen—CXCL8—Allograft Rejection—IL13—systemic scleroderma	0.000307	0.0124	CbGpPWpGaD
Ketoprofen—CXCL8—PERK regulates gene expression—CCL2—systemic scleroderma	0.000305	0.0123	CbGpPWpGaD
Ketoprofen—PTGS2—smooth muscle tissue—systemic scleroderma	0.000304	0.0127	CbGeAlD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.000301	0.0122	CbGpPWpGaD
Ketoprofen—PTGS2—skin of body—systemic scleroderma	0.0003	0.0126	CbGeAlD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.0003	0.0121	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IL13—systemic scleroderma	0.000298	0.012	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—AIF1—systemic scleroderma	0.000298	0.012	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—SELP—systemic scleroderma	0.000296	0.0119	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.000278	0.0112	CbGpPWpGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000277	0.0112	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—RHOB—systemic scleroderma	0.000276	0.0112	CbGpPWpGaD
Ketoprofen—ALB—Lipoprotein metabolism—HSPG2—systemic scleroderma	0.000276	0.0111	CbGpPWpGaD
Ketoprofen—CYP2C9—digestive system—systemic scleroderma	0.000275	0.0115	CbGeAlD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IRF5—systemic scleroderma	0.000272	0.011	CbGpPWpGaD
Ketoprofen—CXCR1—Differentiation Pathway—TGFB1—systemic scleroderma	0.000258	0.0104	CbGpPWpGaD
Ketoprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.000257	0.0104	CbGpPWpGaD
Ketoprofen—PTGS1—digestive system—systemic scleroderma	0.000251	0.0105	CbGeAlD
Ketoprofen—CXCL8—Allograft Rejection—CTLA4—systemic scleroderma	0.000247	0.00997	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.000244	0.00984	CbGpPWpGaD
Ketoprofen—PTGS2—digestive system—systemic scleroderma	0.00024	0.01	CbGeAlD
Ketoprofen—PTGS1—tendon—systemic scleroderma	0.000239	0.01	CbGeAlD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—MMP2—systemic scleroderma	0.000237	0.00957	CbGpPWpGaD
Ketoprofen—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000233	0.0094	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.000232	0.00936	CbGpPWpGaD
Ketoprofen—PTGS2—tendon—systemic scleroderma	0.000228	0.00956	CbGeAlD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—systemic scleroderma	0.000217	0.00877	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000217	0.00876	CbGpPWpGaD
Ketoprofen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—systemic scleroderma	0.000215	0.00868	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—EDN1—systemic scleroderma	0.000214	0.00865	CbGpPWpGaD
Ketoprofen—CXCR1—Peptide ligand-binding receptors—EDN1—systemic scleroderma	0.000213	0.00862	CbGpPWpGaD
Ketoprofen—PTGS1—lung—systemic scleroderma	0.000209	0.00878	CbGeAlD
Ketoprofen—CXCL8—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000203	0.00821	CbGpPWpGaD
Ketoprofen—PTGS2—lung—systemic scleroderma	0.0002	0.00839	CbGeAlD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000194	0.00784	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL1A—systemic scleroderma	0.000193	0.0078	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—CD40LG—systemic scleroderma	0.000192	0.00776	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic scleroderma	0.000188	0.00758	CbGpPWpGaD
Ketoprofen—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000185	0.00746	CbGpPWpGaD
Ketoprofen—ALB—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	0.000183	0.00741	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—MMP1—systemic scleroderma	0.00018	0.00727	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000178	0.0072	CbGpPWpGaD
Ketoprofen—CXCL8—Chemokine receptors bind chemokines—CCL2—systemic scleroderma	0.000175	0.00706	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.000174	0.00704	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—CSF1—systemic scleroderma	0.000161	0.0065	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.00016	0.00645	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	0.000159	0.0064	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.000156	0.0063	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL1A—systemic scleroderma	0.000154	0.00621	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IL1A—systemic scleroderma	0.000154	0.00621	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.00015	0.00605	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP2—systemic scleroderma	0.00015	0.00604	CbGpPWpGaD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—TGFB1—systemic scleroderma	0.000147	0.00593	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—CCL2—systemic scleroderma	0.000146	0.00591	CbGpPWpGaD
Ketoprofen—CXCR1—Peptide ligand-binding receptors—CCL2—systemic scleroderma	0.000146	0.00589	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000145	0.00587	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.000143	0.00578	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—SELP—systemic scleroderma	0.000143	0.00578	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.00014	0.00566	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IL1A—systemic scleroderma	0.00014	0.00566	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.000136	0.0055	CbGpPWpGaD
Ketoprofen—CXCL8—Unfolded Protein Response (UPR)—CCL2—systemic scleroderma	0.000134	0.00542	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.000131	0.00529	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—SELP—systemic scleroderma	0.00013	0.00523	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	0.000125	0.00505	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000121	0.0049	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—RHOB—systemic scleroderma	0.000121	0.00488	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—RHOB—systemic scleroderma	0.000121	0.00487	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000119	0.00482	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.000119	0.00481	CbGpPWpGaD
Ketoprofen—Vomiting—Mometasone—systemic scleroderma	0.000119	0.000906	CcSEcCtD
Ketoprofen—Dry mouth—Lisinopril—systemic scleroderma	0.000119	0.000904	CcSEcCtD
Ketoprofen—Feeling abnormal—Azathioprine—systemic scleroderma	0.000118	0.0009	CcSEcCtD
Ketoprofen—Rash—Mometasone—systemic scleroderma	0.000118	0.000898	CcSEcCtD
Ketoprofen—Asthenia—Captopril—systemic scleroderma	0.000118	0.000897	CcSEcCtD
Ketoprofen—Dermatitis—Mometasone—systemic scleroderma	0.000118	0.000897	CcSEcCtD
Ketoprofen—Decreased appetite—Leflunomide—systemic scleroderma	0.000118	0.000896	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000118	0.000896	CcSEcCtD
Ketoprofen—Confusional state—Lisinopril—systemic scleroderma	0.000118	0.000893	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000117	0.000893	CcSEcCtD
Ketoprofen—Headache—Mometasone—systemic scleroderma	0.000117	0.000892	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000117	0.00089	CcSEcCtD
Ketoprofen—Insomnia—Mycophenolic acid—systemic scleroderma	0.000117	0.00089	CcSEcCtD
Ketoprofen—Fatigue—Leflunomide—systemic scleroderma	0.000117	0.000889	CcSEcCtD
Ketoprofen—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000117	0.000886	CcSEcCtD
Ketoprofen—Oedema—Lisinopril—systemic scleroderma	0.000117	0.000886	CcSEcCtD
Ketoprofen—Pruritus—Captopril—systemic scleroderma	0.000116	0.000885	CcSEcCtD
Ketoprofen—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000116	0.000883	CcSEcCtD
Ketoprofen—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000882	CcSEcCtD
Ketoprofen—Constipation—Leflunomide—systemic scleroderma	0.000116	0.000882	CcSEcCtD
Ketoprofen—Infection—Lisinopril—systemic scleroderma	0.000116	0.00088	CcSEcCtD
Ketoprofen—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000879	CcSEcCtD
Ketoprofen—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000115	0.000877	CcSEcCtD
Ketoprofen—Somnolence—Mycophenolic acid—systemic scleroderma	0.000115	0.000874	CcSEcCtD
Ketoprofen—CXCL8—IL-3 Signaling Pathway—TGFB1—systemic scleroderma	0.000115	0.00463	CbGpPWpGaD
Ketoprofen—Shock—Lisinopril—systemic scleroderma	0.000115	0.000872	CcSEcCtD
Ketoprofen—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000869	CcSEcCtD
Ketoprofen—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000114	0.000867	CcSEcCtD
Ketoprofen—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000114	0.000866	CcSEcCtD
Ketoprofen—Tachycardia—Lisinopril—systemic scleroderma	0.000114	0.000865	CcSEcCtD
Ketoprofen—Abdominal pain—Azathioprine—systemic scleroderma	0.000114	0.000863	CcSEcCtD
Ketoprofen—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000858	CcSEcCtD
Ketoprofen—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000113	0.000856	CcSEcCtD
Ketoprofen—Diarrhoea—Captopril—systemic scleroderma	0.000113	0.000856	CcSEcCtD
Ketoprofen—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000112	0.000855	CcSEcCtD
Ketoprofen—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000854	CcSEcCtD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP9—systemic scleroderma	0.000112	0.00454	CbGpPWpGaD
Ketoprofen—Erectile dysfunction—Prednisone—systemic scleroderma	0.000112	0.000852	CcSEcCtD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000112	0.00453	CbGpPWpGaD
Ketoprofen—Feeling abnormal—Leflunomide—systemic scleroderma	0.000112	0.00085	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000112	0.000849	CcSEcCtD
Ketoprofen—Fatigue—Mycophenolic acid—systemic scleroderma	0.000112	0.000848	CcSEcCtD
Ketoprofen—Nausea—Mometasone—systemic scleroderma	0.000111	0.000846	CcSEcCtD
Ketoprofen—Anorexia—Lisinopril—systemic scleroderma	0.000111	0.000844	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000111	0.000843	CcSEcCtD
Ketoprofen—Weight increased—Prednisone—systemic scleroderma	0.000111	0.000842	CcSEcCtD
Ketoprofen—Constipation—Mycophenolic acid—systemic scleroderma	0.000111	0.000841	CcSEcCtD
Ketoprofen—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00084	CcSEcCtD
Ketoprofen—Weight decreased—Prednisone—systemic scleroderma	0.00011	0.000837	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—RHOB—systemic scleroderma	0.00011	0.00442	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—EDN1—systemic scleroderma	0.000109	0.0044	CbGpPWpGaD
Ketoprofen—Dizziness—Captopril—systemic scleroderma	0.000109	0.000827	CcSEcCtD
Ketoprofen—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000824	CcSEcCtD
Ketoprofen—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000821	CcSEcCtD
Ketoprofen—Urticaria—Leflunomide—systemic scleroderma	0.000108	0.000819	CcSEcCtD
Ketoprofen—Abdominal pain—Leflunomide—systemic scleroderma	0.000107	0.000815	CcSEcCtD
Ketoprofen—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000107	0.000813	CcSEcCtD
Ketoprofen—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000107	0.00081	CcSEcCtD
Ketoprofen—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000107	0.00081	CcSEcCtD
Ketoprofen—Myocardial infarction—Prednisone—systemic scleroderma	0.000106	0.000809	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000106	0.000807	CcSEcCtD
Ketoprofen—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000807	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000106	0.000806	CcSEcCtD
Ketoprofen—Hypersensitivity—Azathioprine—systemic scleroderma	0.000106	0.000804	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000106	0.000804	CcSEcCtD
Ketoprofen—Insomnia—Lisinopril—systemic scleroderma	0.000105	0.000801	CcSEcCtD
Ketoprofen—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000105	0.0008	CcSEcCtD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—NOS3—systemic scleroderma	0.000105	0.00423	CbGpPWpGaD
Ketoprofen—Paraesthesia—Lisinopril—systemic scleroderma	0.000105	0.000795	CcSEcCtD
Ketoprofen—Vomiting—Captopril—systemic scleroderma	0.000105	0.000795	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—MMP9—systemic scleroderma	0.000105	0.00423	CbGpPWpGaD
Ketoprofen—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000792	CcSEcCtD
Ketoprofen—Dyspnoea—Lisinopril—systemic scleroderma	0.000104	0.00079	CcSEcCtD
Ketoprofen—Rash—Captopril—systemic scleroderma	0.000104	0.000789	CcSEcCtD
Ketoprofen—Dermatitis—Captopril—systemic scleroderma	0.000104	0.000788	CcSEcCtD
Ketoprofen—Somnolence—Lisinopril—systemic scleroderma	0.000104	0.000788	CcSEcCtD
Ketoprofen—Headache—Captopril—systemic scleroderma	0.000103	0.000784	CcSEcCtD
Ketoprofen—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000783	CcSEcCtD
Ketoprofen—Dyspepsia—Lisinopril—systemic scleroderma	0.000103	0.00078	CcSEcCtD
Ketoprofen—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000102	0.000777	CcSEcCtD
Ketoprofen—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000776	CcSEcCtD
Ketoprofen—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000776	CcSEcCtD
Ketoprofen—Asthma—Methotrexate—systemic scleroderma	0.000102	0.000773	CcSEcCtD
Ketoprofen—Infection—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000771	CcSEcCtD
Ketoprofen—Decreased appetite—Lisinopril—systemic scleroderma	0.000101	0.00077	CcSEcCtD
Ketoprofen—CXCL8—Allograft Rejection—IL1B—systemic scleroderma	0.000101	0.00407	CbGpPWpGaD
Ketoprofen—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000101	0.000765	CcSEcCtD
Ketoprofen—Fatigue—Lisinopril—systemic scleroderma	0.0001	0.000764	CcSEcCtD
Ketoprofen—Shock—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000764	CcSEcCtD
Ketoprofen—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00076	CcSEcCtD
Ketoprofen—Hypersensitivity—Leflunomide—systemic scleroderma	9.99e-05	0.00076	CcSEcCtD
Ketoprofen—Pancreatitis—Methotrexate—systemic scleroderma	9.98e-05	0.000758	CcSEcCtD
Ketoprofen—Constipation—Lisinopril—systemic scleroderma	9.97e-05	0.000758	CcSEcCtD
Ketoprofen—Tachycardia—Mycophenolate mofetil—systemic scleroderma	9.97e-05	0.000758	CcSEcCtD
Ketoprofen—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	9.87e-05	0.00075	CcSEcCtD
Ketoprofen—Diarrhoea—Azathioprine—systemic scleroderma	9.83e-05	0.000747	CcSEcCtD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	9.78e-05	0.00395	CbGpPWpGaD
Ketoprofen—Nausea—Captopril—systemic scleroderma	9.78e-05	0.000743	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—IL1A—systemic scleroderma	9.74e-05	0.00393	CbGpPWpGaD
Ketoprofen—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.74e-05	0.00074	CcSEcCtD
Ketoprofen—Asthenia—Leflunomide—systemic scleroderma	9.73e-05	0.00074	CcSEcCtD
Ketoprofen—Hallucination—Prednisone—systemic scleroderma	9.7e-05	0.000737	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—CCL2—systemic scleroderma	9.64e-05	0.00389	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—EDN1—systemic scleroderma	9.63e-05	0.00389	CbGpPWpGaD
Ketoprofen—Feeling abnormal—Lisinopril—systemic scleroderma	9.61e-05	0.00073	CcSEcCtD
Ketoprofen—Pruritus—Leflunomide—systemic scleroderma	9.6e-05	0.000729	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Lisinopril—systemic scleroderma	9.53e-05	0.000724	CcSEcCtD
Ketoprofen—Dizziness—Azathioprine—systemic scleroderma	9.5e-05	0.000722	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic scleroderma	9.4e-05	0.0038	CbGpPWpGaD
Ketoprofen—Erectile dysfunction—Methotrexate—systemic scleroderma	9.37e-05	0.000712	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	9.3e-05	0.000707	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Methotrexate—systemic scleroderma	9.29e-05	0.000706	CcSEcCtD
Ketoprofen—Asthenia—Mycophenolic acid—systemic scleroderma	9.29e-05	0.000706	CcSEcCtD
Ketoprofen—Diarrhoea—Leflunomide—systemic scleroderma	9.28e-05	0.000705	CcSEcCtD
Ketoprofen—Urticaria—Lisinopril—systemic scleroderma	9.26e-05	0.000704	CcSEcCtD
Ketoprofen—Insomnia—Mycophenolate mofetil—systemic scleroderma	9.24e-05	0.000702	CcSEcCtD
Ketoprofen—Abdominal pain—Lisinopril—systemic scleroderma	9.21e-05	0.0007	CcSEcCtD
Ketoprofen—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	9.17e-05	0.000697	CcSEcCtD
Ketoprofen—Pruritus—Mycophenolic acid—systemic scleroderma	9.16e-05	0.000696	CcSEcCtD
Ketoprofen—Vomiting—Azathioprine—systemic scleroderma	9.13e-05	0.000694	CcSEcCtD
Ketoprofen—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	9.11e-05	0.000692	CcSEcCtD
Ketoprofen—Somnolence—Mycophenolate mofetil—systemic scleroderma	9.08e-05	0.00069	CcSEcCtD
Ketoprofen—Drowsiness—Methotrexate—systemic scleroderma	9.07e-05	0.000689	CcSEcCtD
Ketoprofen—Rash—Azathioprine—systemic scleroderma	9.06e-05	0.000688	CcSEcCtD
Ketoprofen—Dermatitis—Azathioprine—systemic scleroderma	9.05e-05	0.000688	CcSEcCtD
Ketoprofen—Flushing—Prednisone—systemic scleroderma	9.04e-05	0.000687	CcSEcCtD
Ketoprofen—Headache—Azathioprine—systemic scleroderma	9e-05	0.000684	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	8.99e-05	0.000683	CcSEcCtD
Ketoprofen—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	8.99e-05	0.000683	CcSEcCtD
Ketoprofen—Dizziness—Leflunomide—systemic scleroderma	8.97e-05	0.000682	CcSEcCtD
Ketoprofen—Renal failure—Methotrexate—systemic scleroderma	8.92e-05	0.000678	CcSEcCtD
Ketoprofen—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.88e-05	0.000675	CcSEcCtD
Ketoprofen—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.85e-05	0.000673	CcSEcCtD
Ketoprofen—Stomatitis—Methotrexate—systemic scleroderma	8.84e-05	0.000672	CcSEcCtD
Ketoprofen—Conjunctivitis—Methotrexate—systemic scleroderma	8.82e-05	0.00067	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	8.82e-05	0.00067	CcSEcCtD
Ketoprofen—Constipation—Mycophenolate mofetil—systemic scleroderma	8.73e-05	0.000664	CcSEcCtD
Ketoprofen—Arrhythmia—Prednisone—systemic scleroderma	8.7e-05	0.000662	CcSEcCtD
Ketoprofen—Sweating—Methotrexate—systemic scleroderma	8.7e-05	0.000661	CcSEcCtD
Ketoprofen—Haematuria—Methotrexate—systemic scleroderma	8.65e-05	0.000657	CcSEcCtD
Ketoprofen—Vomiting—Leflunomide—systemic scleroderma	8.63e-05	0.000655	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—TGFB1—systemic scleroderma	8.62e-05	0.00348	CbGpPWpGaD
Ketoprofen—Alopecia—Prednisone—systemic scleroderma	8.61e-05	0.000654	CcSEcCtD
Ketoprofen—Hypersensitivity—Lisinopril—systemic scleroderma	8.59e-05	0.000653	CcSEcCtD
Ketoprofen—Dizziness—Mycophenolic acid—systemic scleroderma	8.56e-05	0.00065	CcSEcCtD
Ketoprofen—Epistaxis—Methotrexate—systemic scleroderma	8.56e-05	0.00065	CcSEcCtD
Ketoprofen—Rash—Leflunomide—systemic scleroderma	8.55e-05	0.00065	CcSEcCtD
Ketoprofen—Dermatitis—Leflunomide—systemic scleroderma	8.55e-05	0.000649	CcSEcCtD
Ketoprofen—Nausea—Azathioprine—systemic scleroderma	8.53e-05	0.000648	CcSEcCtD
Ketoprofen—Headache—Leflunomide—systemic scleroderma	8.5e-05	0.000646	CcSEcCtD
Ketoprofen—Erythema—Prednisone—systemic scleroderma	8.48e-05	0.000645	CcSEcCtD
Ketoprofen—Agranulocytosis—Methotrexate—systemic scleroderma	8.47e-05	0.000643	CcSEcCtD
Ketoprofen—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	8.42e-05	0.00064	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—SMAD7—systemic scleroderma	8.37e-05	0.00338	CbGpPWpGaD
Ketoprofen—Asthenia—Lisinopril—systemic scleroderma	8.36e-05	0.000636	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	8.35e-05	0.000635	CcSEcCtD
Ketoprofen—Pruritus—Lisinopril—systemic scleroderma	8.25e-05	0.000627	CcSEcCtD
Ketoprofen—Vomiting—Mycophenolic acid—systemic scleroderma	8.23e-05	0.000625	CcSEcCtD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	8.21e-05	0.00332	CbGpPWpGaD
Ketoprofen—Rash—Mycophenolic acid—systemic scleroderma	8.16e-05	0.00062	CcSEcCtD
Ketoprofen—Dermatitis—Mycophenolic acid—systemic scleroderma	8.15e-05	0.00062	CcSEcCtD
Ketoprofen—Hepatitis—Methotrexate—systemic scleroderma	8.14e-05	0.000619	CcSEcCtD
Ketoprofen—Urticaria—Mycophenolate mofetil—systemic scleroderma	8.11e-05	0.000617	CcSEcCtD
Ketoprofen—Headache—Mycophenolic acid—systemic scleroderma	8.11e-05	0.000616	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—systemic scleroderma	8.08e-05	0.000614	CcSEcCtD
Ketoprofen—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	8.07e-05	0.000614	CcSEcCtD
Ketoprofen—Nausea—Leflunomide—systemic scleroderma	8.06e-05	0.000612	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IL1B—systemic scleroderma	8.02e-05	0.00324	CbGpPWpGaD
Ketoprofen—Diarrhoea—Lisinopril—systemic scleroderma	7.98e-05	0.000606	CcSEcCtD
Ketoprofen—Ill-defined disorder—Prednisone—systemic scleroderma	7.87e-05	0.000598	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—systemic scleroderma	7.85e-05	0.000596	CcSEcCtD
Ketoprofen—Anaemia—Prednisone—systemic scleroderma	7.84e-05	0.000596	CcSEcCtD
Ketoprofen—CXCL8—Allograft Rejection—TGFB1—systemic scleroderma	7.83e-05	0.00316	CbGpPWpGaD
Ketoprofen—Angioedema—Prednisone—systemic scleroderma	7.75e-05	0.000589	CcSEcCtD
Ketoprofen—Dizziness—Lisinopril—systemic scleroderma	7.71e-05	0.000586	CcSEcCtD
Ketoprofen—Erythema multiforme—Methotrexate—systemic scleroderma	7.7e-05	0.000585	CcSEcCtD
Ketoprofen—Nausea—Mycophenolic acid—systemic scleroderma	7.69e-05	0.000584	CcSEcCtD
Ketoprofen—Malaise—Prednisone—systemic scleroderma	7.65e-05	0.000581	CcSEcCtD
Ketoprofen—Vertigo—Prednisone—systemic scleroderma	7.62e-05	0.000579	CcSEcCtD
Ketoprofen—Tinnitus—Methotrexate—systemic scleroderma	7.59e-05	0.000577	CcSEcCtD
Ketoprofen—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.52e-05	0.000572	CcSEcCtD
Ketoprofen—CXCR1—GPCR ligand binding—CCL2—systemic scleroderma	7.45e-05	0.00301	CbGpPWpGaD
Ketoprofen—Vomiting—Lisinopril—systemic scleroderma	7.41e-05	0.000563	CcSEcCtD
Ketoprofen—CXCL8—Cellular responses to stress—IL1A—systemic scleroderma	7.36e-05	0.00297	CbGpPWpGaD
Ketoprofen—Rash—Lisinopril—systemic scleroderma	7.35e-05	0.000559	CcSEcCtD
Ketoprofen—Convulsion—Prednisone—systemic scleroderma	7.35e-05	0.000559	CcSEcCtD
Ketoprofen—Dermatitis—Lisinopril—systemic scleroderma	7.34e-05	0.000558	CcSEcCtD
Ketoprofen—Asthenia—Mycophenolate mofetil—systemic scleroderma	7.33e-05	0.000557	CcSEcCtD
Ketoprofen—Hypertension—Prednisone—systemic scleroderma	7.32e-05	0.000557	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—IL1B—systemic scleroderma	7.31e-05	0.00295	CbGpPWpGaD
Ketoprofen—Chills—Methotrexate—systemic scleroderma	7.31e-05	0.000555	CcSEcCtD
Ketoprofen—Headache—Lisinopril—systemic scleroderma	7.3e-05	0.000555	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—SELP—systemic scleroderma	7.23e-05	0.00292	CbGpPWpGaD
Ketoprofen—Pruritus—Mycophenolate mofetil—systemic scleroderma	7.23e-05	0.000549	CcSEcCtD
Ketoprofen—Myalgia—Prednisone—systemic scleroderma	7.22e-05	0.000549	CcSEcCtD
Ketoprofen—Anxiety—Prednisone—systemic scleroderma	7.2e-05	0.000547	CcSEcCtD
Ketoprofen—Alopecia—Methotrexate—systemic scleroderma	7.2e-05	0.000547	CcSEcCtD
Ketoprofen—Discomfort—Prednisone—systemic scleroderma	7.14e-05	0.000542	CcSEcCtD
Ketoprofen—Erythema—Methotrexate—systemic scleroderma	7.09e-05	0.000539	CcSEcCtD
Ketoprofen—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.99e-05	0.000531	CcSEcCtD
Ketoprofen—Dysgeusia—Methotrexate—systemic scleroderma	6.94e-05	0.000528	CcSEcCtD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	6.93e-05	0.0028	CbGpPWpGaD
Ketoprofen—Nausea—Lisinopril—systemic scleroderma	6.92e-05	0.000526	CcSEcCtD
Ketoprofen—Anaphylactic shock—Prednisone—systemic scleroderma	6.92e-05	0.000526	CcSEcCtD
Ketoprofen—Oedema—Prednisone—systemic scleroderma	6.92e-05	0.000526	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—MMP9—systemic scleroderma	6.89e-05	0.00278	CbGpPWpGaD
Ketoprofen—Infection—Prednisone—systemic scleroderma	6.88e-05	0.000523	CcSEcCtD
Ketoprofen—Shock—Prednisone—systemic scleroderma	6.81e-05	0.000518	CcSEcCtD
Ketoprofen—Tachycardia—Prednisone—systemic scleroderma	6.76e-05	0.000513	CcSEcCtD
Ketoprofen—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.75e-05	0.000513	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—RHOB—systemic scleroderma	6.75e-05	0.00272	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—CCL2—systemic scleroderma	6.72e-05	0.00272	CbGpPWpGaD
Ketoprofen—Hyperhidrosis—Prednisone—systemic scleroderma	6.69e-05	0.000509	CcSEcCtD
Ketoprofen—ALB—Vitamin B12 Metabolism—CCL2—systemic scleroderma	6.68e-05	0.0027	CbGpPWpGaD
Ketoprofen—ABCC4—Ectoderm Differentiation—CCL2—systemic scleroderma	6.66e-05	0.00269	CbGpPWpGaD
Ketoprofen—Anorexia—Prednisone—systemic scleroderma	6.6e-05	0.000501	CcSEcCtD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CCL2—systemic scleroderma	6.58e-05	0.00266	CbGpPWpGaD
Ketoprofen—Ill-defined disorder—Methotrexate—systemic scleroderma	6.58e-05	0.0005	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—systemic scleroderma	6.55e-05	0.000498	CcSEcCtD
Ketoprofen—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.49e-05	0.000493	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—RHOB—systemic scleroderma	6.47e-05	0.00261	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	6.46e-05	0.00261	CbGpPWpGaD
Ketoprofen—Rash—Mycophenolate mofetil—systemic scleroderma	6.44e-05	0.000489	CcSEcCtD
Ketoprofen—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.43e-05	0.000489	CcSEcCtD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	6.41e-05	0.00259	CbGpPWpGaD
Ketoprofen—Headache—Mycophenolate mofetil—systemic scleroderma	6.4e-05	0.000486	CcSEcCtD
Ketoprofen—Malaise—Methotrexate—systemic scleroderma	6.39e-05	0.000486	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—systemic scleroderma	6.37e-05	0.000484	CcSEcCtD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	6.34e-05	0.00256	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Prednisone—systemic scleroderma	6.31e-05	0.000479	CcSEcCtD
Ketoprofen—Insomnia—Prednisone—systemic scleroderma	6.26e-05	0.000476	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	6.24e-05	0.00252	CbGpPWpGaD
Ketoprofen—Paraesthesia—Prednisone—systemic scleroderma	6.22e-05	0.000472	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—EDN1—systemic scleroderma	6.16e-05	0.00249	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—CSK—systemic scleroderma	6.15e-05	0.00248	CbGpPWpGaD
Ketoprofen—Convulsion—Methotrexate—systemic scleroderma	6.14e-05	0.000467	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—IL1A—systemic scleroderma	6.14e-05	0.00248	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HSPG2—systemic scleroderma	6.1e-05	0.00246	CbGpPWpGaD
Ketoprofen—Dyspepsia—Prednisone—systemic scleroderma	6.09e-05	0.000463	CcSEcCtD
Ketoprofen—ABCC4—Platelet degranulation—TGFB1—systemic scleroderma	6.07e-05	0.00245	CbGpPWpGaD
Ketoprofen—Nausea—Mycophenolate mofetil—systemic scleroderma	6.07e-05	0.000461	CcSEcCtD
Ketoprofen—Myalgia—Methotrexate—systemic scleroderma	6.04e-05	0.000459	CcSEcCtD
Ketoprofen—Decreased appetite—Prednisone—systemic scleroderma	6.02e-05	0.000457	CcSEcCtD
Ketoprofen—Fatigue—Prednisone—systemic scleroderma	5.97e-05	0.000454	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—systemic scleroderma	5.96e-05	0.000453	CcSEcCtD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	5.92e-05	0.00239	CbGpPWpGaD
Ketoprofen—Constipation—Prednisone—systemic scleroderma	5.92e-05	0.00045	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—CSK—systemic scleroderma	5.89e-05	0.00238	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	5.85e-05	0.00236	CbGpPWpGaD
Ketoprofen—Confusional state—Methotrexate—systemic scleroderma	5.83e-05	0.000443	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methotrexate—systemic scleroderma	5.79e-05	0.00044	CcSEcCtD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	5.78e-05	0.00234	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ITGAM—systemic scleroderma	5.78e-05	0.00233	CbGpPWpGaD
Ketoprofen—Infection—Methotrexate—systemic scleroderma	5.75e-05	0.000437	CcSEcCtD
Ketoprofen—Feeling abnormal—Prednisone—systemic scleroderma	5.7e-05	0.000434	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—TGFB1—systemic scleroderma	5.68e-05	0.00229	CbGpPWpGaD
Ketoprofen—Thrombocytopenia—Methotrexate—systemic scleroderma	5.66e-05	0.00043	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Prednisone—systemic scleroderma	5.66e-05	0.00043	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methotrexate—systemic scleroderma	5.59e-05	0.000425	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—EDN1—systemic scleroderma	5.59e-05	0.00226	CbGpPWpGaD
Ketoprofen—Anorexia—Methotrexate—systemic scleroderma	5.51e-05	0.000419	CcSEcCtD
Ketoprofen—Urticaria—Prednisone—systemic scleroderma	5.5e-05	0.000418	CcSEcCtD
Ketoprofen—Abdominal pain—Prednisone—systemic scleroderma	5.47e-05	0.000416	CcSEcCtD
Ketoprofen—CXCL8—GPCR downstream signaling—RHOB—systemic scleroderma	5.44e-05	0.0022	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—CCL2—systemic scleroderma	5.44e-05	0.0022	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	5.39e-05	0.00218	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.36e-05	0.00217	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—CCL2—systemic scleroderma	5.34e-05	0.00216	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	5.27e-05	0.000401	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—systemic scleroderma	5.23e-05	0.000398	CcSEcCtD
Ketoprofen—Paraesthesia—Methotrexate—systemic scleroderma	5.2e-05	0.000395	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—systemic scleroderma	5.16e-05	0.000392	CcSEcCtD
Ketoprofen—Somnolence—Methotrexate—systemic scleroderma	5.14e-05	0.000391	CcSEcCtD
Ketoprofen—Hypersensitivity—Prednisone—systemic scleroderma	5.1e-05	0.000388	CcSEcCtD
Ketoprofen—PTGS1—Selenium Micronutrient Network—IL1B—systemic scleroderma	5.1e-05	0.00206	CbGpPWpGaD
Ketoprofen—Dyspepsia—Methotrexate—systemic scleroderma	5.09e-05	0.000387	CcSEcCtD
Ketoprofen—ALB—Vitamin B12 Metabolism—IL1B—systemic scleroderma	5.07e-05	0.00205	CbGpPWpGaD
Ketoprofen—Decreased appetite—Methotrexate—systemic scleroderma	5.03e-05	0.000382	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.99e-05	0.00038	CcSEcCtD
Ketoprofen—Fatigue—Methotrexate—systemic scleroderma	4.99e-05	0.000379	CcSEcCtD
Ketoprofen—Asthenia—Prednisone—systemic scleroderma	4.97e-05	0.000377	CcSEcCtD
Ketoprofen—CXCL8—Signaling by GPCR—RHOB—systemic scleroderma	4.94e-05	0.002	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—EDN1—systemic scleroderma	4.92e-05	0.00199	CbGpPWpGaD
Ketoprofen—Pruritus—Prednisone—systemic scleroderma	4.9e-05	0.000372	CcSEcCtD
Ketoprofen—Feeling abnormal—Methotrexate—systemic scleroderma	4.77e-05	0.000362	CcSEcCtD
Ketoprofen—Diarrhoea—Prednisone—systemic scleroderma	4.74e-05	0.00036	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.73e-05	0.00036	CcSEcCtD
Ketoprofen—Urticaria—Methotrexate—systemic scleroderma	4.6e-05	0.000349	CcSEcCtD
Ketoprofen—Dizziness—Prednisone—systemic scleroderma	4.58e-05	0.000348	CcSEcCtD
Ketoprofen—Abdominal pain—Methotrexate—systemic scleroderma	4.57e-05	0.000348	CcSEcCtD
Ketoprofen—CXCL8—Metabolism of proteins—ACE—systemic scleroderma	4.53e-05	0.00183	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	4.42e-05	0.00178	CbGpPWpGaD
Ketoprofen—Vomiting—Prednisone—systemic scleroderma	4.4e-05	0.000335	CcSEcCtD
Ketoprofen—Rash—Prednisone—systemic scleroderma	4.36e-05	0.000332	CcSEcCtD
Ketoprofen—Dermatitis—Prednisone—systemic scleroderma	4.36e-05	0.000331	CcSEcCtD
Ketoprofen—Headache—Prednisone—systemic scleroderma	4.34e-05	0.00033	CcSEcCtD
Ketoprofen—ALB—Selenium Micronutrient Network—CCL2—systemic scleroderma	4.32e-05	0.00174	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Methotrexate—systemic scleroderma	4.26e-05	0.000324	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—CCL2—systemic scleroderma	4.22e-05	0.0017	CbGpPWpGaD
Ketoprofen—Asthenia—Methotrexate—systemic scleroderma	4.15e-05	0.000315	CcSEcCtD
Ketoprofen—ALB—Folate Metabolism—IL1B—systemic scleroderma	4.12e-05	0.00167	CbGpPWpGaD
Ketoprofen—Nausea—Prednisone—systemic scleroderma	4.11e-05	0.000313	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—systemic scleroderma	4.09e-05	0.000311	CcSEcCtD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.08e-05	0.00165	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.07e-05	0.00164	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—IL1B—systemic scleroderma	4.05e-05	0.00163	CbGpPWpGaD
Ketoprofen—Diarrhoea—Methotrexate—systemic scleroderma	3.96e-05	0.000301	CcSEcCtD
Ketoprofen—Dizziness—Methotrexate—systemic scleroderma	3.83e-05	0.000291	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—CCL2—systemic scleroderma	3.82e-05	0.00154	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SMAD7—systemic scleroderma	3.78e-05	0.00152	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—TGFB1—systemic scleroderma	3.75e-05	0.00152	CbGpPWpGaD
Ketoprofen—Vomiting—Methotrexate—systemic scleroderma	3.68e-05	0.00028	CcSEcCtD
Ketoprofen—Rash—Methotrexate—systemic scleroderma	3.65e-05	0.000277	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—systemic scleroderma	3.64e-05	0.000277	CcSEcCtD
Ketoprofen—Headache—Methotrexate—systemic scleroderma	3.62e-05	0.000275	CcSEcCtD
Ketoprofen—Nausea—Methotrexate—systemic scleroderma	3.44e-05	0.000261	CcSEcCtD
Ketoprofen—CXCL8—GPCR ligand binding—CCL2—systemic scleroderma	3.36e-05	0.00136	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EDN1—systemic scleroderma	3.3e-05	0.00133	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IL1B—systemic scleroderma	3.28e-05	0.00132	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SELP—systemic scleroderma	3.27e-05	0.00132	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.24e-05	0.00131	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL1B—systemic scleroderma	3.2e-05	0.00129	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.09e-05	0.00125	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—RHOB—systemic scleroderma	3.05e-05	0.00123	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MMP9—systemic scleroderma	3.02e-05	0.00122	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RHOB—systemic scleroderma	2.92e-05	0.00118	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MMP1—systemic scleroderma	2.91e-05	0.00117	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—MMP1—systemic scleroderma	2.9e-05	0.00117	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—CSK—systemic scleroderma	2.78e-05	0.00112	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—EDN1—systemic scleroderma	2.78e-05	0.00112	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HSPG2—systemic scleroderma	2.75e-05	0.00111	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—TGFB1—systemic scleroderma	2.75e-05	0.00111	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.69e-05	0.00109	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CSK—systemic scleroderma	2.66e-05	0.00107	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.64e-05	0.00106	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.62e-05	0.00106	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	2.62e-05	0.00106	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—ITGAM—systemic scleroderma	2.61e-05	0.00106	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EDN1—systemic scleroderma	2.52e-05	0.00102	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TGFB1—systemic scleroderma	2.49e-05	0.001	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.46e-05	0.000992	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—HSPG2—systemic scleroderma	2.39e-05	0.000965	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—CCL2—systemic scleroderma	2.37e-05	0.000955	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SMAD7—systemic scleroderma	2.36e-05	0.000954	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCL2—systemic scleroderma	2.26e-05	0.000912	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MMP2—systemic scleroderma	2.25e-05	0.000909	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFBI—systemic scleroderma	2.16e-05	0.000872	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.15e-05	0.000866	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NOS3—systemic scleroderma	2.1e-05	0.000848	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NOS3—systemic scleroderma	2.01e-05	0.000813	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2e-05	0.000807	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.99e-05	0.000802	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HSPG2—systemic scleroderma	1.82e-05	0.000734	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CTGF—systemic scleroderma	1.81e-05	0.000731	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCL2—systemic scleroderma	1.73e-05	0.000697	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HSPG2—systemic scleroderma	1.72e-05	0.000696	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.69e-05	0.000683	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CSK—systemic scleroderma	1.66e-05	0.000672	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.63e-05	0.000657	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP9—systemic scleroderma	1.62e-05	0.000652	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD247—systemic scleroderma	1.56e-05	0.000632	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EDN1—systemic scleroderma	1.49e-05	0.000602	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HSPG2—systemic scleroderma	1.44e-05	0.000583	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TGFB1—systemic scleroderma	1.39e-05	0.000561	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CTGF—systemic scleroderma	1.38e-05	0.000556	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TGFB1—systemic scleroderma	1.33e-05	0.000538	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—MMP1—systemic scleroderma	1.31e-05	0.000529	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.22e-05	0.000492	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HSPG2—systemic scleroderma	1.17e-05	0.000474	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HSPG2—systemic scleroderma	1.17e-05	0.000471	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CTGF—systemic scleroderma	1.09e-05	0.000442	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL2—systemic scleroderma	1.02e-05	0.000412	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HSPG2—systemic scleroderma	9.56e-06	0.000386	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS3—systemic scleroderma	9.5e-06	0.000384	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOS3—systemic scleroderma	9.09e-06	0.000367	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CTGF—systemic scleroderma	8.9e-06	0.000359	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CTGF—systemic scleroderma	8.85e-06	0.000357	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NOS3—systemic scleroderma	7.88e-06	0.000318	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—systemic scleroderma	7.29e-06	0.000294	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CTGF—systemic scleroderma	7.24e-06	0.000292	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TGFB1—systemic scleroderma	6.28e-06	0.000254	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFB1—systemic scleroderma	6.01e-06	0.000243	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NOS3—systemic scleroderma	6e-06	0.000242	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS3—systemic scleroderma	5.68e-06	0.00023	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NOS3—systemic scleroderma	4.76e-06	0.000192	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NOS3—systemic scleroderma	3.87e-06	0.000156	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NOS3—systemic scleroderma	3.85e-06	0.000156	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFB1—systemic scleroderma	3.76e-06	0.000152	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NOS3—systemic scleroderma	3.15e-06	0.000127	CbGpPWpGaD
